Metabolic system alterations in pancreatic cancer patient serum: potential for early detection

BACKGROUND: The prognosis of pancreatic cancer (PC) is one of the poorest among all cancers, due largely to the lack of methods for screening and early detection. New biomarkers for identifying high-risk or early-stage subjects could significantly impact PC mortality. The goal of this study was to f...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Ritchie, Shawn A, Akita, Hirofumi, Takemasa, Ichiro, Eguchi, Hidetoshi, Pastural, Elodie, Nagano, Hiroaki, Monden, Morito, Doki, Yuichiro, Mori, Masaki, Jin, Wei, Sajobi, Tolulope T, Jayasinghe, Dushmanthi, Chitou, Bassirou, Yamazaki, Yasuyo, White, Thayer, Goodenowe, Dayan B
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2013
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3847543/
https://ncbi.nlm.nih.gov/pubmed/24024929
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-416
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak